Target intelligence / Profile preview

Resolve blood stasis and detoxify (HXJD)

Target
HXJD
Molecular classification
Therapeutic principle, Traditional Chinese Medicine strategy, Pharmacological action
01

Overview

"Resolve blood stasis and detoxify" (Huoxue Jiedu) is a fundamental therapeutic principle in Traditional Chinese Medicine (TCM) used to treat complex diseases characterized by impaired blood circulation (stasis) and inflammatory toxemia (detoxification). Unlike a singular molecular target such as a specific receptor or enzyme, it represents a multi-component and multi-target pharmacological strategy that addresses the underlying pathophysiology of conditions like cardiovascular disease, sepsis, and chronic inflammation. This principle is typically achieved through complex herbal formulas that interact with various biological pathways, including the PI3K/Akt/mTOR signaling axis, the NLRP3 inflammasome, and the coagulation cascade. Research indicates that drugs and formulas following this principle can effectively reduce myocardial injury, prevent thrombosis, and alleviate systemic inflammatory responses by regulating a network of proteins rather than a single site. Consequently, while not a single molecule, it is a highly relevant concept in network pharmacology and integrative medicine for its synergistic effects on vascular and immune health.

Other names
Huoxue JieduActivating blood and removing toxinsPromoting blood circulation and removing detoxificationHXJDHuoxue Jiedu FormulaHuoxue Jiedu Fang
02

Mechanism of action

Multi-target regulation including inhibition of the PI3K/Akt signaling pathway, suppression of NLRP3 inflammasome activation (NLRP3/Caspase-1/IL-1β pathway), reduction of inflammatory cytokines (IL-1β, TNF-α), and inhibition of platelet aggregation and coagulation factors.

03

Biological functions

Anti-inflammatoryAnti-thromboticAntioxidantRegulation of blood circulationImmune modulationAutophagy regulation
04

Disease associations

Cardiovascular diseaseInflammationSepsisChronic kidney diseaseIschemic heart diseaseLiver diseaseThrombosis
05

Safety considerations

Increased risk of bleedingPotential for herb-drug interactions with clinical anticoagulants or antiplateletsGastrointestinal discomfort
06

Interacting drugs

Xuefu Zhuyu Tang

6 more in the full profile.

07

Biomarkers

D-dimerC-reactive protein (CRP)Interleukin-1 beta (IL-1β)FibrinogenCreatine kinase-MB (CK-MB)Cardiac troponin T (cTnT)

Beyond the preview

Go deeper on Resolve blood stasis and detoxify (HXJD).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Resolve blood stasis and detoxify (HXJD).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call